"Lunchtime" Cosmetics: Advancements in Minimally Invasive Procedures
Do you have wrinkles, facial folds, crow's feet, or bags under your eyes and want to do something about it, but are intimidated by major surgery or don't have the time or money for a facelift? You now have more options than ever for reversing these signs of aging. The most recent development is minimally invasive facelifts, like FeatherLift®, that take less than an hour and require almost no recovery time.
The facial filler industry has also seen an influx of products. Besides BOTOX® injection, which has been the number one cosmetic procedure for the past several years, there are now a wide variety of facial fillers to choose from. The composition of products ranges from the botulinum toxin in BOTOX® to collagen and fat injections containing animal byproducts to synthetic products that won't cause allergic reactions. Products also vary in price and how long they last after injection.
How Skin Ages
One of the most common misconceptions about facial skin changes is that it can be attributed mainly to gravity. In fact, the largest contributing factors are fat loss and sun damage. Patients who suffer premature signs of aging as a result of sun damage often opt for skin rejuvenation products like chemical peels, Obagi Blue Peels, or microdermabrasion. To increase fullness in cheeks, chins, lips, and other areas of the face, injectable fillers such as BOTOX® and Radiance, among others, are the preferred option. With a wide variety of products available, patients usually receive optimum results when choosing a surgeon or dermatologist with a lot of experience performing minimally invasive procedures.
Most of these procedures carry with them miniscule, if any, associated complications, and can be performed in such a short period of time that they are commonly referred to as "lunchtime" procedures. This is just one factor contributing to the rise in popularity of these types of procedures. According to statistics from the American Society of Plastic Surgeons (ASPS), over 7 million minimally invasive surgical procedures were performed in 2003, and with recent FDA approvals of Sculptratm and Restylane® facial fillers, that number promises to increase.